Antiadhesive effect of fibrinogen: A safeguard for thrombus stability

Blood

Volumn 109, Issue 4, 2007, Pages 1541-1549

  Lishko, Valeryi K ^a   Burke, Timothy ^a   Ugarova, Tatiana ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRINOGEN; INTEGRIN;

ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; NEUTROPHIL; PRIORITY JOURNAL; THROMBUS;

EID: 33846911014     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-05-022764     Document Type: Article

References (48)

1. Altieri DC, Bader R, Mannucci PM, Edgington TS. Oligospecificity of the cellular adhesion receptor MAC-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol. 1988;107:1893-1900.
2. Loike JD, Sodeik B, Cao L, et al. CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the Aα chain of fibrinogen. Proc Natl Acad Sci U S A. 1991;88:1044-1048.
3. 2, an adhesion receptor up-regulated on macrophage foam cells, exhibits multiligand binding properties. Blood. 2006;107:1643-1650.
4. 1 integrins by chemoattractants regulates neutrophil migration through fibrin. J Cell Biol. 1999;144:1047-1056.
5. Wright SD, Weitz JI, Huang AJ, Levin SM, Silverstein SC, Loike JD. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc Natl Acad Sci U S A. 1988;85:7734-7738.
6. Kuijper PHM, Torres G, Lammers J-WJ, Sixma JJ, Koenderman L, Zwaginga JJ. Platelet and fibrin deposition at the damaged vessel wall: cooperative substrates for neutrophil adhesion under flow conditions. Blood. 1997;89:166-175.
7. Kuijper PHM, Torres HIG, van der Linden JAM, et al. Neutrophil adhesion to fibrinogen and fibrin under flow conditions is diminished by activation and L-selectin shedding. Blood. 1997;89:2131-2138.
8. Altieri DC, Mannucci PM, Capitanio AM. Binding of fibrinogen to human monocytes. J Clin Invest. 1986;78:968-976.
9. Gustafson EJ, Lukasiewicz H, Wachtfogel YT, et al. High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets. J Cell Biol. 1989;109:377-387.
10. Shimaoka M, Takagi J, Springer TA. Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct. 2002;31:485-516.
11. 2 in the γC-domain of fibrinogen. Biochemistry. 2002;41:12942-12951.
12. van Aken PJ, Emeis JJ. Organization of experimentally induced arterial thrombosis in rats: the first six days. Artery. 1982;11:156-173.
13. McGuiness CL, Humphries J, Waltham M, Burnand KG, Collins M, Smith A. Recruitment of labelled monocytes by experimental venous thrombi. Thromb Haemost. 2001;85:1018-1024.
14. Plow EF. The contribution of leukocyte proteases to fibrinolysis. Blut. 1986;53:1-9.
15. Adams SA, Kelly SL, Robson SC, Shephard EG. Role of neutrophil membrane proteases in fibrin degradation. Blood Coagul Fibrinolysis. 1995;6:693-702.
16. Herren T, Swaisgood CM, Plow EF. Regulation of plasminogen receptors. Frontiers Biosci. 2003;8:1-8.
17. Barnhart MI. Importance of neutrophilic leukocytes in the resolution of fibrin. Fed Proc. 1965;24:846-853.
18. Simon DI, Ezratty AM, Francis SA, Rennke H, Loscalzo J. Fibrin(ogen) is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): z nonplasmin fibrinolytic pathway. Blood. 1993;82:2414-2422.
19. Doolittle RF. Fibrinogen and fibrin. Annu Rev Biochem. 1984;53:195-229.
20. Belitser VA, Pozdnjakova TM, Ugarova TP. Light and heavy fractions of fragment D: preparation and examination of fibrin-binding properties. Thromb Res. 1980;19:807-814.
21. 1 during cell migration to fibronectin. Exp Cell Res. 2003; 283: 116-126.
22. Miles LA, Plow EF. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells. Thromb Haemost. 1987;58:936-942.
23. Olson JD, Zaleski A, Herrimann D, Flood PA. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and risrocetin. J Lab Clin Med. 1989;14:6-18.
24. Heene DL, Matthias FR. Thromb Res. 1973;2:137-154.
25. 2 within the gamma-chain of fibrinogen. J Biol Chem. 1998;273:22519-22527.
26. Husain SS, Weisel JW, Budzynski AZ. Interaction of fibrinogen and its derivatives with fibrin. J Biol Chem. 1989;264:11414-11420.
27. Gollwitzer R, Bode W, Karges HE. On the aggregation of fibrinogen molecules. Thromb Res. 1983;(suppl 5):41-53.
28. Schielen WJG, Voskuilen M, Tesser GI, Nieuwenhuizen W. The sequence A-alpha-(148-160) in fibrin, but not in fibrinogen is accessible to monoclonal antibodies. Proc Natl Acad Sci U S A. 1989;86:8951-8954.
29. Zamarron C, Ginsberg MH, Plow EF. Monoclonal antibodies specific for a conformationally altered state of fibrinogen. Thromb Haemost. 1990;64:41-46.
30. Makogonenko EM, Tsurupa G, Ingham K, Medved L. Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site. Biochemistry. 2002;41:7907-7913.
31. Ugarova TP, Yakubenko VP. Recognition of fibrinogen by leukocyte integrins. Ann N Y Acad Sci. 2001;936:368-386.
32. Flick MJ, Du X, Witte DP, et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest. 2004;113:1596-1606.
33. Lorand L. Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. Ann N Y Acad Sci. 2001;936:291-311.
34. Disher DE, Janmey PA, Wang Y-L. Tissue cells feel and respond to the stiffness of their substrate. Science. 2005;310:1139-1143.
35. Giannone G, Sheetz MP. Substrate rigidity and force define form through tyrosine phosphatase and kinase pathways. Trends Cell Biol. 2006;16:213-223.
36. Altieri DC, Agbanyo FR, Plescia J, Ginsberg MH, Edgington TS, Plow EF. A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CDIIb/CD18). J Biol Chem. 1990;265:12119-12122.
37. Moskowitz KA, Kudryk B, Coller BS. Fibrinogen coating density affects the conformation of immobilized fibrinogen: implications for platelet adhesion and spreading. Thromb Haemost. 1998;79:824-831.
38. Lishko VK, Podolnikova NP, Yakubenko VP, et al. Multiple binding sites in fibrinogen for integrin alpha Mbeta 2 (Mac-1). J Biol Chem. 2004;279:44897-44906.
39. Yakovlev S, Zhang L, Ugarova TP, Medved L. Interaction of fibrin(ogen) with leukocyte receptor alphaMbeta2 (Mac-1): further characterization and identification of a novel binding region within the central domain of the fibrinogen gamma-module. Biochemistry. 2005;44:617-626.
40. Garcia-Pardo A, Ferreira OC, Valinsky J, Bianco C. Fibronectin receptors of mononuclear phagocytes: binding characteristics and biochemical isolation. Exp Cell Res. 1989;181:420-431.
41. Nathan C, Srimal S, Farber C, et al. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J Cell Biol. 1989;109:1341-1349.
42. 1(VLA-5). Blood. 2004;104:719-726.
43. Leung LLK, Nachman RL. Complex formation of platelet thrombospondin with fibrinogen. J Clin Invest. 1982;70:542-549.
44. Podor TJ, Campbell S, Chindemi P, et al. Incorporation of vitronectin into fibrin clots: evidence for a binding interaction between vitronectin and gamma A/gamma′ fibrinogen. J Biol Chem. 2002;277:7520-7528.
45. Varadi A, Patthy L. Location of plasminogen-binding sites in human fibrin(ogen). Biochemistry. 1983;22:2440-2446.
46. Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvascular Res. 1973;5:167-179.
47. Heynen HFG, Molero ML, de Groot PG, Nieuwenhuis HK, Sixma JJ. Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood. J Clin Invest. 1994;94:1098-1112.
48. van Ryn J, Lorenz M, Merk H, Buchanan M, Eisert WG. Accumulation of radiolabeled platelets and fibrin on the carotid artery of rabbits after angioplasty: effects of heparin and dipyridamole. Thromb Haemost. 2003;90:1179-1186.